Alector, Inc. (ALEC) vs Cartesian Therapeutics, Inc. (RNAC)

A side-by-side comparison of Alector, Inc. and Cartesian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALEC vs RNAC

growth of $100 · dividends reinvested · last 8y
ALEC -88.9% (-24.1%/yr)RNAC -86.3% (-22.0%/yr)RNAC compounded faster over this window
0100200300Start $100202120232025$11$14
ALEC RNAC

ALEC vs RNAC: by the numbers

  • •ALEC is the larger company ($205M vs $203M market cap).
  • •Both run net losses; ALEC's is the smaller (-850.13% vs -10422.48% net margin).
  • •Both shrank revenue over the past five years; ALEC's decline was smaller (-8.35% vs -50.01% CAGR).

Metrics side by side

Valuation

MetricALECRNAC
P/S ratio14.82137.71

Profitability

MetricALECRNAC
Gross margin54.09%100.00%
Operating margin-692.83%-3099.93%
Net margin-850.13%-10422.48%
ROIC-71.04%-33.10%

Growth (annualized)

MetricALECRNAC
Revenue CAGR (5Y)-8.35%-50.01%
Total return CAGR (5Y)-39.17%-44.03%

Frequently asked

Which has grown faster, ALEC or RNAC?
Neither grew: over the past five years both shrank revenue, with ALEC's decline the smaller — ALEC at a -8.35% CAGR versus RNAC at -50.01%.
How have ALEC and RNAC total returns compared?
Over the past 5 years, ALEC delivered -39.17% and RNAC delivered -44.03% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.